We are live on ! Find out more
RA

Ramius Advisors Portfolio holdings

AUM $95.2M
1-Year Est. Return 7.33%
This Fund
S&P 500
This Quarter Est. Return
+32.12%
1 Year Est. Return
+7.33%
3 Year Est. Return
+186.73%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$233M
AUM Growth
-$193M
Cap. Flow
-$211M
Cap. Flow %
-90.87%
Top 10 Hldgs %
82.3%
Holding
91
New
44
Increased
8
Reduced
9
Closed
29

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$28M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$10.1M
3
TECD
Tech Data Corp
TECD
+$9.56M
4
CY
Cypress Semiconductor
CY
+$9.47M
5
BOLD
Audentes Therapeutics, Inc
BOLD
+$8.29M

Top Sells

Rank Stock Value
1
MLNX
Mellanox Technologies, Ltd.
MLNX
+$70.6M
2
CELG
Celgene Corp
CELG
+$68.9M
3
GHDX
Genomic Health, Inc.
GHDX
+$29.2M
4
ACIA
Acacia Communications Inc
ACIA
+$23.6M
5
AGN
Allergan plc
AGN
+$21.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.54%
2 Technology 17.91%
3 Consumer Discretionary 4.3%
4 Communication Services 3.04%
5 Financials 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$58.2M 25.02%
304,271
-118,661
-28% -$21.4M
MDCO
2
DELISTED
Medicines Co
MDCO
$35.7M 15.34%
+419,826
New +$28M
ZAYO
3
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$19.8M 8.5%
570,547
+68,170
+14% +$2.33M
CY
4
DELISTED
Cypress Semiconductor
CY
$19.6M 8.44%
841,045
+404,831
+93% +$9.47M
BOLD
5
DELISTED
Audentes Therapeutics, Inc
BOLD
$13.2M 5.68%
+220,784
New +$8.29M
WCG
6
DELISTED
Wellcare Health Plans, Inc.
WCG
$11.9M 5.14%
36,158
+33,658
+1,346% +$10.1M
TECD
7
DELISTED
Tech Data Corp
TECD
$10.7M 4.59%
+74,327
New +$9.56M
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
$7.9M 3.4%
+259,111
New +$6.78M
WBC
9
DELISTED
WABCO HOLDINGS INC.
WBC
$7.67M 3.3%
56,614
-71,571
-56% -$9.65M
TSG
10
DELISTED
The Stars Group Inc.
TSG
$6.74M 2.9%
+258,350
New +$5.78M
S
11
DELISTED
Sprint Corporation
S
$6.12M 2.63%
1,174,868
-1,172,826
-50% -$6.87M
ACIA
12
DELISTED
Acacia Communications Inc
ACIA
$4.95M 2.13%
72,937
-355,828
-83% -$23.6M
AVX
13
DELISTED
AVX Corporation
AVX
$3.17M 1.36%
+154,722
New +$2.66M
ALLK
14
DELISTED
Allakos
ALLK
$2.89M 1.24%
+30,342
New +$2.67M
AMTD
15
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.77M 1.19%
+55,760
New +$2.42M
RARX
16
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.6M 1.12%
+55,487
New +$2.45M
BMY.RT
17
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.33M 1%
+774,191
New +$2.01M
LOGM
18
DELISTED
LogMein, Inc.
LOGM
$1.8M 0.77%
+20,997
New +$1.56M
MLNX
19
DELISTED
Mellanox Technologies, Ltd.
MLNX
$1.43M 0.61%
12,194
-621,286
-98% -$70.6M
TIF
20
DELISTED
Tiffany & Co.
TIF
$1.27M 0.55%
+9,540
New +$1.13M
QGEN icon
21
Qiagen
QGEN
$8.49B
$1.27M 0.55%
+35,494
New +$1.32M
STLA icon
22
Stellantis
STLA
$16.8B
$1.24M 0.53%
+84,398
New +$1.22M
AXE
23
DELISTED
Anixter International Inc
AXE
$1.24M 0.53%
+13,439
New +$1.09M
RESI
24
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$1.2M 0.52%
+97,091
New +$1.15M
WCC
25
WESCO International
WCC
$16B
$1.16M 0.5%
+19,500
New +$1.02M
1
2 3 4

Similar funds

ACM
Acrisure Capital Management Austin, Texas $98.8M AUM
CWM
Catalyst Wealth Management Atlanta, Georgia $107M AUM
HLCM
Hickory Lane Capital Management New York $81.7M AUM 4.68% 1-Year Est. Return
ETM
Euclidean Technologies Management Seattle, Washington $109M AUM 7.18% 1-Year Est. Return
CFA
Compass Financial Advisors Fort Wayne, Indiana $78.9M AUM 0.9% 1-Year Est. Return
ACM
Ascendant Capital Management Los Angeles, California $75.7M AUM 12.68% 1-Year Est. Return
UPC
Utah Peaks Capital Park City, Utah $75.4M AUM
AMC
Asset Management Corp Northbrook, Illinois $128M AUM 6.72% 1-Year Est. Return

Ramius Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Ramius Advisors held 91 positions worth $233M, down 45% from $426M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Ramius Advisors withdrew a net $211M in Q4 2019, closing 29 positions and reducing 9 holdings. Its most notable exit was Celgene Corp, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Ramius Advisors opened a new position in Medicines Co worth $35.7M.

  • Ramius Advisors's largest Q4 2019 buy was Medicines Co: 419,826 shares worth $35.7M.
  • Ramius Advisors added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $10.1M increase.
  • Ramius Advisors's biggest Q4 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $70.6M.
  • Ramius Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $68.9M.
  • Ramius Advisors's ten largest holdings make up 82% of its $233M portfolio in Q4 2019.
  • Ramius Advisors opened 44 new positions and closed 29 in Q4 2019.
  • Ramius Advisors's portfolio value fell 45% quarter-over-quarter to $233M.

Based on Ramius Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.